LONDON, UK – Ingenion Medical Limited announces that Susan Finch joined the senior management of the company as Chief Operating Officer to support the pre-commercialization activities and launch of its groundbreaking CymActive SoftValve device to treat non-neurogenic chronic urinary retention in men.  The CymActive SoftValve is the first in a range of devices from Ingenion to treat chronic urinary control issues.

Ed Cappabianca, CEO of Ingenion Medical, said: “Ingenion is very pleased to announce the appointment of Susan Finch as our Chief Operating Officer.  Susan joins our team following a
successful 25-year career in operations and senior management roles in both medical devices and industrial manufacturing industries for both privately held and large international blue-chip
companies.  Most recently, Susan spent 7 years as General Manager for Pennine Healthcare, in addition to years of operational management experience in other industries with companies such as
Bosch and ICO Polymers.  Susan received her MBA from Nottingham University Business school.

“Susan’s comprehensive understanding of the quality and regulatory requirements of the medical device sector, including bringing her previous company through the transition from MDD to MDR will be of
significant value to Ingenion, as we are bringing our lead product through the CE Marking process. She has also successfully built and led a number of diverse teams during a challenging period to ensure that critical healthcare products were
supplied to the NHS.”

“Susan will be responsible for implementing Ingenion’s Quality Management System, managing our
contract manufacturing relationships, and supply chains to ensure that Ingenion
is able to provide high quality products to a wide range of healthcare
providers and patients.”

Susan Finch, Chief Operating Officer, commented: “I am
delighted to join Ingenion and support the launch of their innovative,
life-changing CymActive catheter range of medical devices. This product range
will significantly improve the mobility and quality of life for patients who
need this type of device, and I am excited to work closely as a member of the
executive team at Ingenion to bring these much needed products to market.”

Visit for more

Contact: Edward Cappabianca, Chief Executive Officer


Recent posts


LONDON, UK – Ingenion Medical Limited announces that Tim Maloney has joined the senior management of the company as Commercial Director to support the pre-commercialization activities and launch of its ground-breaking CymActive [...]
Read more
Copyright © 2024 - All Rights Reserved
Contact Ingenion Medical to find out if cymactive™️ is approved for sale in your market.